Ann: ResApp secures contract with global pharmaceutical company, page-16

This is a very good result IMO.

J and J are one of the biggest pharmas in the world and have been trying to make an RSV vaccine/therapeutic for a long time. They have an adenoviral vector vaccine trial in kids (similar to the AZ Covid Jab) with trial sites in Australia including Perth. RSV is a very common infection and causes significant hospitalization in children and in vulnerable adults.

I particularly like the fact that J and J think the ResAppDx tech is robust and accurate enough to be included in their trial. j and J trials are large and very tightly regulated. They don’t just throw in “good ideas”.

Well done ResApp team.